-
The Instruction of Levocetirizine dihydrochloride
Time of Update: 2023-04-26
The manufacturing process of levocetirizine dihydrochloride involves several steps including synthesis, purification, and formulation.
The manufacturing process of levocetirizine dihydrochloride involves several steps including synthesis, purification, and formulation.
The manufacturing process of levocetirizine dihydrochloride involves several steps including synthesis, purification, and formulation.
-
State Food and Drug Administration: China's domestic extracorporeal membrane oxygenation therapy (ECMO) products have been approved for marketing
Time of Update: 2023-02-03
According to the State Food and Drug Administration, according to the needs of epidemic prevention and control work, in order to ensure the treatment needs of severe patients with novel coronavirus p
-
The large turtle veterinary drugs sold by Hainan Wanghao Sunshine Industry exceeded the standard
Time of Update: 2023-01-01
, Ltd. and produced by the nominal Wenchang Jinshan Yamei Beef Jerky 20190409 20190407 Processing Factory in Hainan Province, benzoic acid and its sodium salt (in terms of benzoic acid) did not meet the national food safety standards.
-
Chengyi Biologics announced that the GLP-1 receptor agonist ECC5004 has been approved for clinical trial in the United States
Time of Update: 2022-11-15
, Ltd. recently announced that the US Food and Drug Administration (FDA) has approved its application for a clinical trial of the glucagon-like peptide 1 (GLP-1) receptor agonist ECC5004 in the United States for the treatment of type 2 diabetes mellitus (T2DM).
-
Hubei Provincial Market Supervision and Administration Bureau Food Safety Supervision and Sampling Information Announcement (Issue 14, 2022
Time of Update: 2022-10-12
According to the Food Safety Law of the People's Republic of China, the Provincial Bureau has recently organized edible agricultural products, pastries, edible oils, oils and fats and their products,
-
Notice of the State Food and Drug Administration on the Publication of the Catalogue of Generic Drug Reference Preparations (46th Batch) (No. 82 [2021
Time of Update: 2022-10-01
doc to Notice No. 82 [2021] of the State Drug Administration After the review and confirmation of the Expert Committee on the Consistency Evaluation of Generic Drugs and Efficacy of the State Drug Administration, the Catalogue of Generic Drug Reference Preparations (46th Batch) is hereby published.
-
"2018 China Jiaxian Food Culture Week" came to a successful conclusion
Time of Update: 2022-09-24
"2018 China Jiaxian Food Culture Week" with the theme of "Leading the development of Jiaxian food and creating a food feast in the province", successfully organized and carried out the selection of the top ten delicacies in Jiaxian, the 2018 Jiaxian tourism product packaging design selection, and the food breakthrough , Jiaxian Food Award-winning Paipai, Jiaxian Longevity Hometown, Beautiful Home Photography Exhibition and Food Beauty Photography Competition, Jiaxian Food Carnival and other series of activities .
-
n-3 fatty acids: a helper in the fight against aging
Time of Update: 2022-09-04
Research shows that n-3 fatty acids (especially EPA and DHA) can suppress chronic inflammation and oxidative stress, prevent Mitochondrial dysfunction, DNA damage and telomere attrition promote stem cell function, autophagy and nutrient metabolism .
-
Four departments announced 10 key shortage drug reserve enterprises
Time of Update: 2022-08-21
Pharmaceutical Pharmaceutical Enterprise Enterprise Pharmaceutical Medicine Health and Wellness According to the "Gongxin Weibo" official account on the 9th, the Ministry of Industry and Information Technology, the National Health Commission, the National Medical Security Administration, and the State Drug Administration jointly issued a notice to deploy and strengthen the selection of drugs in short supply and centralized procurement of drugs organized by the state.
-
30 novel coronavirus antigen detection reagents have been approved by the State Food and Drug Administration
Time of Update: 2022-05-15
On April 27, the State Food and Drug Administration issued an announcement stating that it re-examined and approved a new coronavirus antigen detection reagent product, specifically the new coronavirus (2019-nCoV) antigen detection kit (latex) of Wuhan Shengzhiyuan Biotechnology Co.
-
China Resources Secco and YaoPharma Acarbose Tablets were approved on the same day
Time of Update: 2022-04-24
com, in 2020, the total sales of acarbose tablets in Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 4 billion yuan, and Bayer has the largest market share .
-
Northeast Pharmaceutical Carboprost Tromethamine Injection was awarded the "Drug Registration Certificate
Time of Update: 2022-03-05
On the evening of February 17, Northeast Pharmaceuticals announced that its wholly-owned subsidiary, No. 1 Pharmaceutical Carprost Tromethamine Injection, received the "Drug Registration Certificate"
-
There are new developments in the research and development of domestic children's drugs, and the drug company's innovative drug is approved for RPDD
Time of Update: 2021-12-30
In short, China's children's drug market is still in a situation where there are few special varieties, fewer suitable dosage forms, fewer manufacturers, and high attention from enterprises but low actual research and development enthusiasm .
-
Gilead Trodelvy receives positive opinion from EU CHMP for treatment of breast cancer
Time of Update: 2021-11-16
CompilationFan DongdongA few days ago, Gilead ADC drug Trodelvy has received positive opinions from the European Medicines Agency (EMA) Committee on Medicinal Products for Human Use (CHMP) for monotherapy in adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) .
-
Walk into AOCC, pay attention to the new progress of IBD interleukin therapy
Time of Update: 2021-10-21
Biologics treatment of CD Infliximab (IFX) was approved for CD indications in China in 2007, officially opening a new era of anti-tumor necrosis factor (TNF) treatment for inflammatory bowel disease in China, bringing new opportunities to patients and doctors Hope .